1. Taiwan, Province of China Stocks

  2. •

    Healthcare

  3. •

    Medical - Devices
Bonraybio Co. Ltd.

Bonraybio Co. Ltd.

6955.TW
Bonraybio Co. Ltd.TW flagTaiwan Stock Exchange
119.00
TWD
-1.00
- -
2.95BMarket Cap

Total Valuation

Bonraybio Co. Ltd. carries a market capitalization of 2.95B, placing it among publicly traded companies globally. Its enterprise value stands at 3.52B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap2.95B
Enterprise Value3.52B

Share Statistics

Bonraybio Co. Ltd. currently has 24.80M shares outstanding.

Shares Outstanding24.80M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

Bonraybio Co. Ltd. trades at a trailing price-to-earnings ratio of 39.76. The price-to-sales ratio is 12.73, and the price-to-book ratio stands at 6.49.

PE Ratio39.76
PS Ratio12.73
PB Ratio6.49
P/TBV Ratio6.77
P/FCF Ratio28.47
P/OCF Ratio35.75

Enterprise Valuation

On an enterprise value basis, Bonraybio Co. Ltd. trades at an EV/EBITDA multiple of 34.28 and an EV/FCF ratio of 24.52. The EV/Sales ratio of 11.01 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 34.28 provides insight into valuation relative to core operating earnings.

EV / Sales11.01
EV / EBITDA34.28
EV / EBIT34.28
EV / FCF24.52

Financial Position

Bonraybio Co. Ltd. maintains a current ratio of 6.80, meaning it holds 6.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.97, indicating moderate leverage, while an interest coverage ratio of 828.02 demonstrates strong ability to service its debt obligations.

Current Ratio6.80
Quick Ratio5.93
Debt / Equity0.97
Debt / EBITDA0.06
Interest Coverage828.02

Financial Efficiency

Bonraybio Co. Ltd. posts a return on equity of 17.18 and a return on invested capital of 16.04.

Return on Equity (ROE)17.18
Return on Assets (ROA)14.98
Return on Invested Capital (ROIC)16.04
Return on Capital Employed (ROCE)16.98
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover2.20

Taxes

Over the trailing twelve months, Bonraybio Co. Ltd. has paid 5.59M in income taxes, reflecting an effective tax rate of 5.18.

Income Tax5.59M
Effective Tax Rate5.18

Stock Price Statistics

Bonraybio Co. Ltd.'s stock has declined approximately -29.27612% over the past 52 weeks. The 50-day moving average sits at 122.29, while the 200-day moving average is 151.92.

Beta (5Y)N/A
52-Week Price Change-29.27612%
50-Day Moving Average122.29
200-Day Moving Average151.92
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Bonraybio Co. Ltd. generated 319.67M in revenue and converted that into 102.36M in net income, yielding earnings per share of 4.12. EBITDA reached 102.68M, while operating income came in at 102.68M.

Revenue319.67M
Gross Profit247.63M
Operating Income102.68M
Pretax Income107.94M
Net Income102.36M
EBITDA102.68M
EBIT102.68M
Earnings Per Share (EPS)4.12

Balance Sheet

Bonraybio Co. Ltd. holds 565.91M in cash and equivalents against 6.11M in total debt, resulting in a net debt position of -263.91M. Total book value stands at 628.27M, with working capital of 553.70M providing operational flexibility.

Cash & Cash Equivalents565.91M
Total Debt6.11M
Net Debt-263.91M
Equity (Book Value)628.27M
Book Value Per Share25.33
Working Capital553.70M

Cash Flow

Bonraybio Co. Ltd. produced 113.83M in operating cash flow over the past twelve months. After subtracting -29.63M in capital expenditures, free cash flow totaled 84.20M - equivalent to 3.40 per share.

Operating Cash Flow113.83M
Capital Expenditures-29.63M
Free Cash Flow84.20M
FCF Per Share3.40

Margins

Bonraybio Co. Ltd. operates with a gross margin of 77.46, reflecting its pricing power and cost economics. The operating margin of 32.12 and net profit margin of 32.02 provide insight into operational efficiency.

Gross Margin77.46
Operating Margin32.12
Pretax Margin33.77
Profit Margin32.02
EBITDA Margin32.12

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield0.87
FCF Yield3.51

Stock Splits

Bonraybio Co. Ltd.'s most recent stock split took place on August 26, 2026 with a 800:989 split ratio.

Last Split Date8/26/2026
Split Ratio800:989

Scores

Bonraybio Co. Ltd. posts an Altman Z-Score of 26.95, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score26.95